Company Filing History:
Years Active: 2016-2017
Title: Innovations by Chun-Mei Hu
Introduction
Chun-Mei Hu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of molecular biology through his innovative research and patents. With a total of two patents to his name, he has focused on developing small molecule modifiers that have potential applications in cancer treatment.
Latest Patents
Chun-Mei Hu's latest patents include advancements in small molecule modifiers of the Hec1-Nek2 interaction in G2/M. Certain embodiments of his invention provide selected compounds with a molecular structure according to a specific formula. In this formula, Z can be —CO—, —SO—, or —SO—; Ar represents phenyl, heteroaryl, or heterocycloalkyl; and Het is heteroaryl. The compounds are designed to inhibit the growth of cell lines such as HeLa and MB468 with a sub-micromolar IC. These innovations hold promise for enhancing cancer therapies.
Career Highlights
Chun-Mei Hu is affiliated with the University of California, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on medical science, particularly in the development of targeted cancer treatments.
Collaborations
Chun-Mei Hu has collaborated with esteemed colleagues, including Wen-Hwa Lee and Jiewen Zhu. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Chun-Mei Hu's contributions to the field of molecular biology through his patents reflect his dedication to innovation and research. His work has the potential to significantly impact cancer treatment methodologies.